(Q44045545)

29 November 2017

Different efficacy of soluble CD14 treatment in high- and low-dose LPS models (English)

1 reference

29 November 2017

Stelter F

1

1 reference

29 November 2017

Witt S

2

1 reference

29 November 2017

Fürll B

3

1 reference

29 November 2017

Jack RS

4

1 reference

29 November 2017

Hartung T

5

1 reference

29 November 2017

Schütt C

6

1 reference

29 November 2017

1 March 1998

1 reference

European Journal of Clinical Investigation

29 November 2017

1 reference

29 November 2017

28

1 reference

29 November 2017

3

1 reference

29 November 2017

205-213

1 reference

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

29 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Septic shock: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

CD14 is a pattern recognition receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Soluble CD14 participates in the response of cells to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Endotoxin-neutralizing capacity of soluble CD14

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Galactosamine-induced sensitization to the lethal effects of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Biochemical pharmacology of inflammatory liver injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

In vivo protection against endotoxin by plasma high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00264.X

10.1046/J.1365-2362.1998.00264.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference